Koenig Sheldon L. - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Koenig Sheldon L.'s relationship to Esperion Therapeutics, Inc. (ESPR) is Director,Officer (President and CEO), and currently has 1,470,587 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Koenig Sheldon L. - Insider Non-Derivative Transactions of ESPR Common Stock
Koenig Sheldon L. - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 18, 2025 Sell -- (Common Stock) 48244 3.67 1470587
Sep 18, 2025 Sell -- (Common Stock) 28427 2.79 1518831
Jun 18, 2025 Sell -- (Common Stock) 30474 1.11 1541488
Mar 19, 2025 Sell -- (Common Stock) 13047 1.5 1571962
Mar 15, 2025 Acquisition -- (Common Stock) 840000 0 1585009
Dec 18, 2024 Sell -- (Common Stock) 12447 2.47 739819
Sep 18, 2024 Sell -- (Common Stock) 14550 1.8 752266
Mar 15, 2024 Acquisition -- (Common Stock) 454000 0 766816
May 10, 2023 P -- (Common Stock) 20000 1.26 312816
Mar 18, 2023 Sell -- (Common Stock) 6999 1.78 292816
Mar 15, 2023 Acquisition -- (Common Stock) 105000 0 299815
Mar 8, 2023 Sell -- (Common Stock) 5441 5.06 194815